Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2021

May 4, 2021

284_dirs_2021-05-04_a4e8ae52-3a6a-45a0-a0c0-4787ba8e6a57.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2021-05-01

Reporting Person: Williams David Michael (EVP,Chief Info&Digital Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-05-01 Common Stock M 560 $74.50 Acquired 5166.757 Direct
2021-05-01 Common Stock F 192 $74.50 Disposed 4974.757 Direct
2021-05-03 Common Stock M 412 $74.50 Acquired 5386.757 Direct
2021-05-03 Common Stock F 142 $74.50 Disposed 5244.757 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-05-01 Restricted Stock Unit $ M 560 Disposed 2023-05-01 Common Stock (560) Direct
2021-05-03 Restricted Stock Unit $ M 412 Disposed 2022-05-03 Common Stock (412) Direct

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F3: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.

F4: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022.